New Insights on Treating Infantile and Epileptic Spasms
Researchers studied a condition called infantile and epileptic spasms syndrome (IESS), which affects infants and can lead to serious developmental issues.
This hub covers drug-resistant epilepsy: When seizures aren’t controlled after trying two appropriate medicines. Research-backed next steps on diet therapies, devices, surgery evaluation, and safety.
If seizures aren’t controlled after two meds, it’s worth at least an evaluation at an epilepsy center.
Not necessarily. Some familiar consider it earlier depending on seizure type and goals.
Yes. Treatment response can change over time, and combinations/approaches matter.
Seizure frequency, triggers, sleep, missed meds, side effects, and rescue med use.
Researchers studied a condition called infantile and epileptic spasms syndrome (IESS), which affects infants and can lead to serious developmental issues.
Researchers studied the effectiveness of trigeminal nerve stimulation (TNS) as a treatment for people with drug-resistant epilepsy (DRE), which means their seizures do not respond to standard medications.
Researchers studied the effectiveness and safety of fenfluramine as a treatment for people with drug-resistant epilepsy, particularly those with conditions like Dravet syndrome and Lennox-Gastaut syndrome.
Researchers studied the satisfaction of patients who had epilepsy surgery by translating and validating a questionnaire called the Epilepsy Surgery Satisfaction Questionnaire-19 (ESSQ_19) into Spanish.
This study looked at the safety of deep brain stimulation (DBS) surgery in children with various conditions, including movement disorders, drug-resistant epilepsy, and self-injurious behavior.
This study looked at how well epilepsy surgery works for people with autism spectrum disorder (ASD) who also have epilepsy.
This study focused on children with a specific type of epilepsy called focal cortical dysplasia (FCD), which often does not respond to medication.
A study was conducted to look at how effective Cenobamate (CNB) is for adults with idiopathic generalized epilepsy (IGE), a type of epilepsy that can be hard to treat.
This study looked at children with drug-resistant epilepsy, which means their seizures do not respond well to medication.